This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

My Cart
Shopping Cart
0 items
£0.00
View Cart

Animal Pharm New Generics Report 2014

Regular Price: £1,750.00

Special Price: £1,172.50

Availability: In stock

SKU: 76287

Quick Overview

Patenting and registration processes; product research and development; company strategies and profiles

Click on image to zoom

You may also be interested in ...

Product Overview

With many of the world’s bestselling active ingredients losing their patent protection, and sales of generic products set to rise significantly over coming years, companies must recoup the cost of developing new drugs, and the cost of speculative research.

This report advises on the threats and opportunities that this brings, along with examples of strategies companies are using to prevent sales of their off-patent active ingredients. This also comprehensively covers patenting and registration issues for new products.

This report will help you understand:

  • What are the threats and how can active ingredient manufacturers minimise effects of losing their patent protection
  • How can companies developing and marketing new products maximise and protect their R&D and product pipelines
  • Discover how the patenting process works in the US, EU and other key markets
  • What strategies do companies use to protect sales of off-patent active ingredients

Format: PDF Report sent by email

*PLEASE NOTE: Price is for Single User License only. For multi-user deals please email reports@agra-net.com

Published: May 2014

Features & Contents

This report will help you understand:

  • What are the threats and how can active ingredient manufacturers minimise effects of losing their patent protection
  • How can companies developing and marketing new products maximise and protect their R&D and product pipelines
  • Discover how the patenting process works in the US, EU and other key markets
  • What strategies do companies use to protect sales of off-patent active ingredients

Click here for contents pages

Click here for the executive summary

Click here for sample pages

More Info

Susan Watkins is a specialist researcher and writer. She graduated with an honours degree in Applied Biology specialising in Crop Protection from the University of Bath, and has more than 15 years of experience in writing business reports for the agrochemical, animal health, and pharmaceutical sectors. She is the author of several successful reports on the generics sector.

Reviews (0)

There are no reviews for this product yet. Be the first to share your experiences.